147 related articles for article (PubMed ID: 25976908)
1. Association between HbA1c levels with severity of coronary artery disease and short-term outcomes of acute ST-elevation myocardial infarction in nondiabetic patients.
Ghaffari S; Niafar F; Separham A; Niafar M; Pourafkari L; Nader ND
Ther Adv Cardiovasc Dis; 2015 Oct; 9(5):305-13. PubMed ID: 25976908
[TBL] [Abstract][Full Text] [Related]
2. General glycosylated hemoglobin goals potentially increase myocardial infarction severity in diabetes patients with comorbidities: Insights from a nationwide multicenter study.
Che Q; Zhang Y; Wang J; Wan Z; Fu X; Chen J; Yan H; Chen Y; Ge J; Chen D; Huo Y
J Diabetes Investig; 2020 Nov; 11(6):1498-1506. PubMed ID: 32383543
[TBL] [Abstract][Full Text] [Related]
3. Hemoglobin A1c and short-term outcomes in patients with acute myocardial infarction undergoing primary angioplasty: an observational multicenter study.
Tian L; Zhu J; Liu L; Liang Y; Li J; Yang Y
Coron Artery Dis; 2013 Jan; 24(1):16-22. PubMed ID: 23168569
[TBL] [Abstract][Full Text] [Related]
4. Impact of elevated HbA1c on long-term mortality in patients presenting with acute myocardial infarction in daily clinical practice: insights from a 'real world' prospective registry of the Zwolle Myocardial Infarction Study Group.
Hermanides RS; Kennedy MW; Kedhi E; van Dijk PR; Timmer JR; Ottervanger JP; Dambrink JH; Gosselink AM; Roolvink V; Miedema K; Slingerland RJ; Koopmans P; Bilo HJ; van 't Hof AW
Eur Heart J Acute Cardiovasc Care; 2020 Sep; 9(6):616-625. PubMed ID: 31124695
[TBL] [Abstract][Full Text] [Related]
5. Coronary artery disease severity modifies associations between glycemic control and both mortality and myocardial infarction.
Raghavan S; Liu WG; Michael Ho P; Plomondon ME; Barón AE; Caplan L; Joynt Maddox KE; Magid D; Saxon DR; Voils CI; Bradley SM; Maddox TM
J Diabetes Complications; 2018 May; 32(5):480-487. PubMed ID: 29483016
[TBL] [Abstract][Full Text] [Related]
6. Glucose dysregulation in nondiabetic patients with ST-elevation myocardial infarction: acute and chronic glucose dysregulation in STEMI.
Rasoul S; Ottervanger JP; Bilo HJ; Timmer JR; van 't Hof AW; Dambrink JH; Dikkeschei LD; Hoorntje JC; de Boer MJ; Zijlstra F
Neth J Med; 2007 Mar; 65(3):95-100. PubMed ID: 17387235
[TBL] [Abstract][Full Text] [Related]
7. Prediabetes and short-term outcomes in nondiabetic patients after acute ST-elevation myocardial infarction.
Tian L; Zhu J; Liu L; Liang Y; Li J; Yang Y
Cardiology; 2014; 127(1):55-61. PubMed ID: 24247598
[TBL] [Abstract][Full Text] [Related]
8. Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Li Y; Li X; Zhang Y; Zhang L; Wu Q; Bai Z; Si J; Zuo X; Shi N; Li J; Chu X
BMC Cardiovasc Disord; 2020 Jan; 20(1):36. PubMed ID: 32000678
[TBL] [Abstract][Full Text] [Related]
9. Impact of initial glycosylated hemoglobin level on cardiovascular outcomes in prediabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shin D; Ahn J; Cha KS; Park JS; Oh JH; Lee HW; Hong JY; Kim BW; Hong TJ;
Coron Artery Dis; 2016 Jan; 27(1):40-6. PubMed ID: 26398151
[TBL] [Abstract][Full Text] [Related]
10. Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Rasoul S; Ottervanger JP; de Boer MJ; Dambrink JH; Hoorntje JC; Marcel Gosselink AT; Zijlstra F; Suryapranata H; van 't Hof AW;
Coron Artery Dis; 2009 Sep; 20(6):415-21. PubMed ID: 19641460
[TBL] [Abstract][Full Text] [Related]
11. Hemoglobin A1c as a prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction.
Cicek G; Uyarel H; Ergelen M; Ayhan E; Abanonu GB; Eren M; Gibson CM
Coron Artery Dis; 2011 May; 22(3):131-7. PubMed ID: 21394027
[TBL] [Abstract][Full Text] [Related]
12. Hemoglobin A
She J; Deng Y; Wu Y; Xia Y; Li H; Liang X; Shi R; Yuan Z
Cardiovasc Diabetol; 2017 Aug; 16(1):97. PubMed ID: 28789650
[TBL] [Abstract][Full Text] [Related]
13. STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry).
Montalescot G; Dallongeville J; Van Belle E; Rouanet S; Baulac C; Degrandsart A; Vicaut E;
Eur Heart J; 2007 Jun; 28(12):1409-17. PubMed ID: 17412730
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of glycated hemoglobin among patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis.
Li G; Hou X; Li Y; Zhang P; Zhao Q; Li J; Shi J
Clin Chem Lab Med; 2017 Jul; 55(8):1090-1099. PubMed ID: 27816956
[TBL] [Abstract][Full Text] [Related]
15. Hemoglobin A1c is a better predictor of prognosis following the non-ST elevation acute coronary syndrome than fasting and admission glucose.
Kmet M; Rajer B; Pernat A
Wien Klin Wochenschr; 2014 Mar; 126(5-6):156-62. PubMed ID: 24297265
[TBL] [Abstract][Full Text] [Related]
16. Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients.
Sia CH; Chan MH; Zheng H; Ko J; Ho AF; Chong J; Foo D; Foo LL; Lim PZ; Liew BW; Chai P; Yeo TC; Tan HC; Chua T; Chan MY; Tan JWC; Bulluck H; Hausenloy DJ
Cardiovasc Diabetol; 2021 Oct; 20(1):211. PubMed ID: 34666746
[TBL] [Abstract][Full Text] [Related]
17. The value of admission HbA(1c) level in diabetic patients with acute coronary syndrome.
Chan CY; Li R; Chan JY; Zhang Q; Chan CP; Dong M; Yan BP; Lam YY; Yu CM
Clin Cardiol; 2011 Aug; 34(8):507-12. PubMed ID: 21717470
[TBL] [Abstract][Full Text] [Related]
18. Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.
Sosnowski C; Janeczko-Sosnowska E; Woźniak J; Jasiński B; Dabrowski R; Sumiński A; Wiernikowski A; Ostrzycki A; Szwed H; Ruzyłło W
Kardiol Pol; 2007 Oct; 65(10):1181-6; discussion 1187-9. PubMed ID: 17979046
[TBL] [Abstract][Full Text] [Related]
19. Clinical influence of early follow-up glycosylated hemoglobin levels on cardiovascular outcomes in diabetic patients with ST-segment elevation myocardial infarction after coronary reperfusion.
Ahn J; Hong TJ; Park JS; Lee HW; Oh JH; Choi JH; Lee HC; Cha KS; Yun E; Jeong MH; Chae SC; Kim YJ; Hur SH; Seong IW; Jang YS; Cho MC; Kim CJ; Seung KB; Rha SW; Bae JH; Park SJ;
Coron Artery Dis; 2015 Nov; 26(7):555-61. PubMed ID: 25933028
[TBL] [Abstract][Full Text] [Related]
20. Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography.
Arbel Y; Zlotnik M; Halkin A; Havakuk O; Berliner S; Herz I; Rabinovich I; Keren G; Bazan S; Finkelstein A; Banai S
Clin Res Cardiol; 2014 Mar; 103(3):223-7. PubMed ID: 24271460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
